Bufei Recipe Reduces the Incidence Rate of COPD
NCT06375824 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1100
Last updated 2024-04-19
Summary
Establish early TCM prevention and treatment program to reduce the incidence rate of COPD.
Conditions
- Preserved Ratio Impaired Spirometry
Interventions
- DRUG
-
Bufei Recipe
Bufei Recipe: Roasted Astragalus, Codonopsis pilosula, Walnut kernels, Sichuan Fritillaria, Angelica sinensis, Stir fried Purple Su Zi, Honey Baibu, Roasted Purple Aster, etc. Take 1 dose daily, 5 days a week.
- DRUG
-
Bufei Recipe placebo
The placebo was prepared using 5% of the drug, with color, odor, taste, appearance, and weight similar to the experimental group drug, and packaging consistent with the experimental group drug.
Sponsors & Collaborators
-
West China Hospital
collaborator OTHER -
The First Affiliated Hospital of Zhejiang Chinese Medical University
collaborator OTHER -
Henan University of Traditional Chinese Medicine
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-05-01
- Primary Completion
- 2027-04-30
- Completion
- 2027-10-31
More Related Trials
-
Respiratory Disease Cohort Studies of Chinese Medicine for Pulmonary Nodule
NCT06673121 ·Status: RECRUITING
-
The Establishment of China Bronchiectasis Registry and Research Collaboration
NCT03643653 ·Status: RECRUITING
-
Treatment of CRF With Syndrome Differentiation of TCM
NCT04694755 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Predictive Value of Inflammatory Biomarkers and FEV1 for COPD
NCT03532893 ·Status: COMPLETED
-
Assessment of an Exhaled Breath Test to Detect Bronchiectasis
NCT05293314 ·Status: COMPLETED
-
Realize the Current Situation of COPD Patients in China
NCT03131362 ·Status: COMPLETED
-
Exhaled Breath Condensate Assessment in Stable Non-Cystic Fibrotic Bronchiectasis
NCT03643263 ·Status: COMPLETED
-
Research on the Characteristics of Chronic Airway Diseases (asthma, COPD)
NCT06685315 ·Status: NOT_YET_RECRUITING
-
A Translational Study for Prediction of Biomarkers and Identification of Phenotype and Endotype of COPD and Early COPD Outcomes in Chinese Population
NCT06724848 ·Status: RECRUITING
-
Autologous Bronchial Basal Cells Transplantation for Treatment of CRD Including COPD, BE and PF
NCT03153800 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Study on the Etiology, Risk Factors and Pathogenesis of COPD Based on Clinical Bioinformatics
NCT05069194 ·Status: UNKNOWN
-
Study on Disease Progression and Nutritional Status in Bronchiectasis
NCT06344000 ·Status: RECRUITING
-
Clinical Features and Airways Inflammation in Never Smokers and Smokers With COPD
NCT03274791 ·Status: COMPLETED
-
Exhaled Breath Condensate Biomarkers and Cough in IPF
NCT02630940 ·Status: COMPLETED
-
Lung Dispersing, Turbid Descending and Gut Clearing Decoction for Bronchiectasis
NCT03177889 ·Status: UNKNOWN ·Phase: NA
-
Management and Healthcare Utilization of Patients With Chronic Airway Disease During the COVID-19 Epidemic
NCT04948216 ·Status: COMPLETED
-
Effect of Curcumin on Lung Inflammation
NCT01514266 ·Status: COMPLETED ·Phase: NA
-
An Observational Registry of Chinese COPD Study
NCT04318912 ·Status: NOT_YET_RECRUITING
-
Air Pollution and Health of COPD Patients
NCT05076630 ·Status: COMPLETED
-
A Clinical Evaluation of Baofeikang Granule in Combined Pulmonary Fibrosis and Emphysema Treatment
NCT02805699 ·Status: UNKNOWN ·Phase: PHASE2
-
The Clinical Characteristics, Treatment and Prognosis of Tuberculosis-associated COPD
NCT06074042 ·Status: RECRUITING
-
Heterogeneity and Development of Early COPD
NCT06096285 ·Status: RECRUITING
-
Traditional Chinese Medicine(TCM) Syndrome Classification of Idiopathic Pulmonary Fibrosis(IPF) and Metabolomics
NCT03711435 ·Status: COMPLETED
-
Autologous Bronchial Basal Cells Transplantation for Treatment of Bronchiectasis
NCT02722642 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Boosting Regional Integration for COP D Care Through Guided Implementation and Audit of Post Exacerbation Transition Bundle
NCT06646419 ·Status: ACTIVE_NOT_RECRUITING